Skip to content

PTGX

Protagonist Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$134.27-4.71%

Price as of Jul 20, 2026

PTGX capital

Protagonist Therapeutics, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.28x
Debt / assets
0.01x
Debt / EBITDA
-0.09x
Net debt / EBITDA
1.61x

Liquidity & coverage

Current ratio
17.76x
Quick ratio
17.76x
Cash ratio
15.86x
Interest coverage
EBITDA / interest
Working capital
$578.9M

Cash & dividend

FCF / debt
-11.90x
Cash flow / debt
-11.93x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.